剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

07666 剂泰科技-P

未开盘 07-08 16:08:17

13.000

-0.200

-1.52%

最高13.860	最低12.600	成交量123.70万
今开13.200	昨收13.200	日振幅9.55%
总市值153.79亿	流通市值140.79亿	总股本11.83亿
成交额1,587万	换手率0.11%	流通股本10.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"剂泰科技-P","latestPrice":13,"timestamp":1783498097931,"preClose":13.2,"halted":0,"volume":1237000,"delay":0,"changeRate":-0.015151515151515098,"floatShares":1083000000,"shares":1183000000,"eps":-4.796383174185709,"marketStatus":"未开盘","change":-0.2,"latestTime":"07-08 16:08:17","open":13.2,"high":13.86,"low":12.6,"amount":15874239,"amplitude":0.095455,"askPrice":13,"askSize":13000,"bidPrice":12.74,"bidSize":12500,"shortable":0,"etf":0,"ttmEps":-0.4227555755889154,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783560600000},"marketStatusCode":0,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":13.2,"openAndCloseTimeList":[[1783474200000,1783483200000],[1783486800000,1783497600000]],"volumeRatio":0.6517726001273153,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/07666","defaultTab":"news","newsList":[{"id":"2649160480","title":"【券商聚焦】国泰海通予剂泰科技(07666)“增持”评级 指双轮驱动模式获验证","url":"https://stock-news.laohu8.com/highlight/detail?id=2649160480","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649160480?lang=zh_cn&edition=full","pubTime":"2026-07-07 14:17","pubTimestamp":1783405072,"startTime":"0","endTime":"0","summary":"该项交易创下中国制药企业临床前TCE项目单笔海外授权交易金额新纪录，潜在交易总额超16亿美元，公司将获得2千万美元首付款。此举被视为中国AI药物递送创新国际化的重要里程碑。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/YTg5NTFiOTlmZmEyYmE3ODE4NjgwNzc4MTUzMTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/YTg5NTFiOTlmZmEyYmE3ODE4NjgwNzc4MTUzMTI=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985272","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666","02611","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184448624","title":"剂泰科技-P更新2026年6月股份变动月报，H股新增发行30,184,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1184448624","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184448624?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:48","pubTimestamp":1783327705,"startTime":"0","endTime":"0","summary":"剂泰科技-P于2026年7月6日公布截至2026年6月30日的股份变动月报。报告期内，公司股份总结构有所变动，主要因全面行使超额配股权所致。经公告披露，境内未上市股份（普通股）维持99,587,739股不变；H股（普通股）则从上月的1,052,926,111股增至1,083,110,111股，增加30,184,000股。这部分增发股份的面值均为人民币0.1元，总计新增注册资本人民币3,018,400元，相关发行价格为每股港币10.5元。本月末，公司法定/注册股本总额为人民币118,269,785元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648630195","title":"剂泰科技-P早盘涨逾6% 达成16亿美元临床前TCE授权合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2648630195","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648630195?lang=zh_cn&edition=full","pubTime":"2026-07-03 11:16","pubTimestamp":1783048560,"startTime":"0","endTime":"0","summary":"　　剂泰科技-P盘中涨超6%，截至发稿，股价上涨5.85%，现报14.29港元，成交额586.49万港元。剂泰科技与Deerfield旗下美国生物科技公司Boulevard Bio达成全球独家许可协议。为此，剂泰科技将斩获2000万美元首付款，并有资格获得最高达到16亿美元的开发、注册及商业化里程碑付款，外加基于产品销售额的分级销售提成。　　据公开披露信息，此次交易创下中国制药企业临床前TCE项目单笔海外授权交易金额新纪录，也是中国AI药物递送创新国际化的重要里程碑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-03/doc-inifnxpe3689297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648637462","title":"港股异动 | 剂泰科技-P(07666.HK)涨超6% 达成16亿美元临床前TCE授权合作 创中国单笔记录","url":"https://stock-news.laohu8.com/highlight/detail?id=2648637462","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648637462?lang=zh_cn&edition=full","pubTime":"2026-07-03 10:17","pubTimestamp":1783045077,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648520162","title":"AI制药的转折点，可能就藏在这笔交易里","url":"https://stock-news.laohu8.com/highlight/detail?id=2648520162","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648520162?lang=zh_cn&edition=full","pubTime":"2026-07-02 09:04","pubTimestamp":1782954267,"startTime":"0","endTime":"0","summary":"一个平台被市场重新定价，很多时候就是这样悄无声息地发生。表面看只是一笔交易公告，但底下其实已经完成了一次价值跃迁。","market":"us","thumbnail":"https://img7.gelonghui.com/column/3.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/3.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5417215","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","BK1191","ARTY","AIPO","BK1574","07666","01477","CHAT","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647453054","title":"55家公司港股通新贵即将喜迎北水流入 入通门槛或已抬升至102.67亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647453054","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647453054?lang=zh_cn&edition=full","pubTime":"2026-07-01 10:09","pubTimestamp":1782871774,"startTime":"0","endTime":"0","summary":"核心规则：市值门槛动态调整截至2026年6月30日，港股通实际纳入门槛已升至102.67亿，剔除门槛达66.89亿。这一指标直接决定了个股在指数中的权重与港股通资格。对于不同上市时长的公司，要求有所不同：对于上市公司而言，维持日均万五左右的换手率是保住港股通资格的关键。数据截止日为每年的6月30日和12月31日，这也是上市公司\"冲关\"港股通的关键时间窗口。","market":"hk","thumbnail":"https://static.tigerbbs.com/0cf777090175126e4590c3b8afdfe41e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0cf777090175126e4590c3b8afdfe41e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461288.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02670","02726","BK4585","01511","02672","07630","02696","06675","00068","00340","03310","02272","03625","01236","02553","06656","02335","BK4588","01191","03355","01021","01392","01956","02616","02723","01286","06872","09630","00863","01866","03388","02526","07666","01609","01133","00376","06106","01081","02142","06938","03887","01651","00600","03661","07688","02632","06658","01779","03277","02729","09637","06636","00100","00412","01440","01672","01879"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2647582925","title":"剂泰科技与Deerfield达成授权合作 潜在交易总额超16亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647582925","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647582925?lang=zh_cn&edition=full","pubTime":"2026-06-30 13:24","pubTimestamp":1782797040,"startTime":"0","endTime":"0","summary":"6月30日，剂泰科技-P（07666）发布公告，宣布与Deerfield旗下的BoulevardBio达成一项高达16亿美元的临床前TCE授权合作。根据该合作协议，公司将获得2000万美元的首付款，并有资格获得最高达16亿美元的开发、注册及商业化里程碑付款，外加基于产品销售额的分级销售提成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606303788169071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647377584","title":"中国临床前TCE单笔海外授权新纪录！剂泰科技(07666.HK)与Deerfield首个战略联盟里程碑落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2647377584","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647377584?lang=zh_cn&edition=full","pubTime":"2026-06-30 12:25","pubTimestamp":1782793507,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171777854","title":"剂泰科技-P宣布与Deerfield达成临床前TCE许可合作，总价值高达16亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171777854","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171777854?lang=zh_cn&edition=full","pubTime":"2026-06-30 12:07","pubTimestamp":1782792479,"startTime":"0","endTime":"0","summary":"剂泰科技-P宣布，已与Deerfield达成一项临床前TCE（T细胞衔接器）许可合作协议。根据协议条款，此项合作的总潜在价值最高可达16亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647347726","title":"港股异动 | 剂泰科技-P(07666.HK)涨超10%  AI制药行业步入价值验证期 公司自研AI纳米递送平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2647347726","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647347726?lang=zh_cn&edition=full","pubTime":"2026-06-29 11:13","pubTimestamp":1782702839,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01477","BK1161","BK1574","BK1191","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642325034","title":"港股异动 | 剂泰科技-P(07666)最高涨近7% 近日正式发布AiProtein平台及抗体设计智能体AARON","url":"https://stock-news.laohu8.com/highlight/detail?id=2642325034","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642325034?lang=zh_cn&edition=full","pubTime":"2026-06-12 14:55","pubTimestamp":1781247352,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P最高涨近7%，截至发稿，涨4.36%，报13.4港元，成交额2171.54万港元。消息面上，近日，据剂泰科技官微消息，公司正式发布AiProtein平台以及抗体设计智能体AARON。AiProtein采用剂泰科技自研“干实验+湿实验+智能体”创新范式，是聚焦蛋白和抗体等大分子的设计平台。作为剂泰科技AI纳米递送平台NanoForge驱动下的第四大核心解决方案，AiProtein与AiLNP、AiRNA和AiTEM共同完成了从蛋白设计、mRNA序列设计和LNP设计的剂泰科技“火箭+卫星”端到端研发闭环。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1161","BK4585","07666","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103193776","title":"异动解读｜剂泰科技-P盘中下跌5.26%，超额配发股份上市流通次日抛压持续释放","url":"https://stock-news.laohu8.com/highlight/detail?id=1103193776","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103193776?lang=zh_cn&edition=full","pubTime":"2026-06-11 10:47","pubTimestamp":1781146078,"startTime":"0","endTime":"0","summary":"6月11日，剂泰科技-P盘中下跌5.26%，报11.53港元，成交额1891.85万港元。该股自5月13日上市首日大涨173%后持续回调，较首日高点回撤显著。消息面上，公司超额配股权已悉数行使，涉及3018.4万股H股按发售价10.50港元发行，该批股份于6月10日正式上市交易，新增流通股供给加大市场抛压。同时，稳定价格期间已于6月7日结束，此前支撑股价的稳定价格机制正式退出，叠加部分国际配售股份未设禁售期，获利了结压力持续释放。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107549508","title":"剂泰科技-P：6月10日发行30,184,000股 普通股，占已发行股本约2.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107549508","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107549508?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:22","pubTimestamp":1781086935,"startTime":"0","endTime":"0","summary":"剂泰科技(北京)股份有限公司（“剂泰科技-P”，股票代码：07666）6月10日发布翌日披露报表，宣布公司根据此前公告所述的超额配股权已于当日悉数行使，共发行及配发30,184,000股H股普通股。\n本次发行股份占发行前公司已发行股本约2.8667%，每股发行价格为10.5港元。上述发行完成后，公司已发行股本由1,052,926,111股增至1,083,110,111股。\n公司董事会确认，本次发行已获正式授权并遵守相关法规及上市规定。公告由董事会主席、执行董事兼首席执行官赖才达签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"剂泰科技-P：6月10日发行30,184,000股 普通股，占已发行股本约2.87%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642447721","title":"剂泰科技-P(07666)根据悉数行使超额配股权而发行3018.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642447721","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642447721?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:20","pubTimestamp":1781086827,"startTime":"0","endTime":"0","summary":"智通财经APP讯，剂泰科技-P(07666)发布公告，该公司于2026年6月10日根据悉数行使超额配股权而发行及配发3018.4万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182529402","title":"异动解读｜剂泰科技-P盘中下跌5.49%，超额配发股份正式上市流通加剧抛压","url":"https://stock-news.laohu8.com/highlight/detail?id=1182529402","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182529402?lang=zh_cn&edition=full","pubTime":"2026-06-10 10:33","pubTimestamp":1781058838,"startTime":"0","endTime":"0","summary":"6月10日，剂泰科技-P盘中下跌5.49%，报12.23港元，成交额866.83万港元。该股自5月13日上市首日大涨173%后持续回调。消息面上，公司此前公告超额配股权已悉数行使，涉及3018.4万股H股按发售价10.50港元发行，该批股份于6月10日正式上市交易，新增流通股供给直接加大市场抛压。同时，稳定价格期间已于6月7日结束，此前支撑股价的稳定价格机制正式退出，叠加部分国际配售股份未设禁售期，获利了结压力持续释放，股价承压态势延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103440354","title":"异动解读｜剂泰科技-P盘中下跌8.18%，稳定价格期间结束叠加超额配发股份即将上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1103440354","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103440354?lang=zh_cn&edition=full","pubTime":"2026-06-08 10:16","pubTimestamp":1780884966,"startTime":"0","endTime":"0","summary":"6月8日，剂泰科技-P盘中下跌8.18%，报13.23港元，成交额1064.59万港元。该股自5月13日上市首日大涨173%后持续回调，较首日高点回撤显著。消息面上，公司于6月5日公告超额配股权已悉数行使，涉及3018.4万股H股，按发售价10.50港元发行，预计6月10日开始上市交易。同时，稳定价格期间已于6月7日结束，意味着此前支撑股价的稳定价格机制正式退出，市场抛压失去对冲。叠加部分国际配售股份未设禁售期，获利了结压力加剧，新股热度加速消退，股价承压态势延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641129451","title":"剂泰科技-P(07666)：悉数行使超额配股权、稳定价格行动及稳定价格期间结束","url":"https://stock-news.laohu8.com/highlight/detail?id=2641129451","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641129451?lang=zh_cn&edition=full","pubTime":"2026-06-05 18:53","pubTimestamp":1780656810,"startTime":"0","endTime":"0","summary":"智通财经APP讯，剂泰科技-P 发布公告，招股章程所述的超额配股权已于2026年6月5日(星期五)获整体协调人悉数行使，涉及合共3018.4万股H股，占于任何超额配股权获行使前全球发售项下初步可供认购的发售股份总数的15%。超额配发股份将由本公司按每股H股10.50港元发行及配发。联交所已批准超额配发股份上市及买卖。超额配发股份预期于2026年6月10日上午九时正开始于联交所主板上市及买卖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161807374","title":"剂泰科技-P更新2026年5月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1161807374","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161807374?lang=zh_cn&edition=full","pubTime":"2026-06-04 21:32","pubTimestamp":1780579933,"startTime":"0","endTime":"0","summary":"2026年6月4日，剂泰科技(北京)股份有限公司-P发布2026年5月股份变动月报表。报告期内，公司已发行股份结构中包括99,587,739股境内未上市普通股及1,052,926,111股H股，注册股本合计人民币115,251,385。上述股份数量较上月底无新增发行、购回或注销，股本维持稳定。同时，公司拥有首发前购股权计划所授出的股份期权共18,394,870份，报告期内未见行使或变动。公司确认其已符合相关公众持股量要求，报告由公司董事会主席、执行董事兼首席执行官赖才达签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198765054","title":"异动解读｜剂泰科技-P盘中下跌5.22%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1198765054","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198765054?lang=zh_cn&edition=full","pubTime":"2026-06-04 10:23","pubTimestamp":1780539789,"startTime":"0","endTime":"0","summary":"6月4日，剂泰科技-P盘中下跌5.22%，报14.9港元，成交额638.7万港元。该股自5月13日上市首日大涨173%后已连续多个交易日回调，较首日高点回撤显著。消息面上，剂泰科技作为全球AI药物递送第一股于5月13日登陆港交所，IPO发售价10.50港元。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。尽管公司近日宣布与Deerfield达成战略联盟并发布AiProtein平台等利好，但新股上市初期市场热度加速消退，股价承压回落态势延续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132882851","title":"异动解读 | 剂泰科技-P盘中大涨5.82% 与全球顶级平台Deerfield达成战略联盟","url":"https://stock-news.laohu8.com/highlight/detail?id=1132882851","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132882851?lang=zh_cn&edition=full","pubTime":"2026-06-01 10:23","pubTimestamp":1780280602,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大涨5.82%，引起了市场的广泛关注。消息面上，公司宣布与全球顶级健康投资与创新平台Deerfield Management达成战略联盟，双方将共同开发新一代体内蛋白药物及免疫疗法，并共同推进合作管线产品的全球商业化进程，这一合作显著增强了市场对公司技术实力和未来增长前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.metistechbio.com","stockEarnings":[{"period":"1week","weight":-0.1536},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.2381},{"period":"ytd","weight":0.2381}],"compareEarnings":[{"period":"1week","weight":0.0576},{"period":"1month","weight":-0.0186},{"period":"3month","weight":-0.0603},{"period":"6month","weight":-0.0775},{"period":"1year","weight":0.0021},{"period":"ytd","weight":-0.0558}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"剂泰科技（北京）股份有限公司是一家主要从事人工智能（AI）纳米材料创新的中国公司。NanoForge是该公司的人工智能驱动纳米科技创新体系的基础，涵盖脂质库、人工智能基础模型、METiS AI智能体、量子化学与分子动力学模拟及人工智能驱动的筛选平台。该公司开发了三大专业的解决方案，包括AiTEM、AiLNP及AiRNA平台，用以模拟、预测及阐释纳米级别的相互作用关系，从而实现对先进纳米材料及其相关有效载荷的合理设计、优化及验证。","exchange":"SEHK","name":"剂泰科技-P","nameEN":"METIS TECHBIO-P"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"剂泰科技-P,07666,剂泰科技-P股票,剂泰科技-P股票老虎,剂泰科技-P股票老虎国际,剂泰科技-P行情,剂泰科技-P股票行情,剂泰科技-P股价,剂泰科技-P股市,剂泰科技-P股票价格,剂泰科技-P股票交易,剂泰科技-P股票购买,剂泰科技-P股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}